Feldman, E R <br/><br/>
Phase II trial of recombinant tumor necrosis factor in disseminated malignant melanoma.  [electronic resource] 

 -  American journal of clinical oncology  Jun 1992 
 - 256-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0277-3732 
<br/><br/><label>Standard No.: </label>10.1097/00000421-199206000-00015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Recombinant Proteins--therapeutic use<br/>Remission Induction<br/>Survival Analysis<br/>Tumor Necrosis Factor-alpha--therapeutic use